(19)
(11) EP 1 135 535 A2

(12)

(88) Date of publication A3:
18.01.2001

(43) Date of publication:
26.09.2001 Bulletin 2001/39

(21) Application number: 99958449.3

(22) Date of filing: 03.12.1999
(51) International Patent Classification (IPC)7: C12Q 1/70, C12Q 1/68, C12N 15/10, C12N 15/34, C12N 1/21, C07K 14/01, C12Q 1/18
(86) International application number:
PCT/IB9902/040
(87) International publication number:
WO 0032/825 (08.06.2000 Gazette 2000/23)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 03.12.1998 US 110992 P
03.06.1999 US 326144
28.09.1999 US 407804
30.09.1999 US 157218 P
01.12.1999 US 168777 P
02.12.1999 US 454252

(71) Applicant: Phagetech Inc.
Montreal H2W 2N9 (CA)

(72) Inventors:
  • PELLETIER, Jerry
    Baie D'Urfe, Quebec H9X 3B1 (CA)
  • GROS, Phillippe
    St. Lambert, Quebec J4R 1X4 (CA)
  • DUBOW, Michael
    Montreal, Quebec H3X 2K8 (CA)

(74) Representative: Viering, Jentschura & Partner 
Postfach 22 14 43
80504 München
80504 München (DE)

   


(54) DEVELOPMENT OF ANTI-MICROBIAL AGENTS BASED ON BACTERIOPHAGE GENOMICS